Ken Fisher Heron Therapeutics, Inc. Transaction History

Fisher Asset Management, LLC

$243 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 12, 2023	BUY	$1.11 - $2.88 $387,655 - $1.01 Million	349,239 New	349,239 $405,000
Q2 2023 Aug 08, 2023	SELL	$1.11 - $2.88 $59,884 - $155,376	-53,950 Reduced 13.38%	349,239 $405,000
Q1 2023 Dec 12, 2023	BUY	$1.51 - $3.25 $608,815 - $1.31 Million	403,189 New	403,189 $608,000
Q1 2023 May 01, 2023	SELL	$1.51 - $3.25 $58 - $126	-39 Reduced 0.01%	403,189 $609,000
Q4 2022 Feb 03, 2023	BUY	$2.25 - $4.67 $500,280 - $1.04 Million	222,347 Added 122.92%	403,228 $1.01 Million
Q3 2022 Nov 08, 2022	SELL	$2.66 - $5.37 $798 - $1,611	-300 Reduced 0.17%	180,881 $763,000
Q2 2022 Aug 09, 2022	BUY	$2.3 - $6.29 $690 - $1,887	300 Added 0.17%	181,181 $505,000
Q1 2022 May 05, 2022	BUY	$4.63 - $9.94 $228,661 - $490,906	49,387 Added 37.56%	180,881 $1.04 Million
Q4 2021 Feb 02, 2022	BUY	$8.35 - $12.6 $805,666 - $1.22 Million	96,487 Added 275.62%	131,494 $1.2 Million
Q3 2021 Oct 26, 2021	BUY	$10.13 - $15.0 $1,013 - $1,500	100 Added 0.29%	35,007 $374,000
Q2 2021 Jul 27, 2021	BUY	$13.27 - $18.48 $2,454 - $3,418	185 Added 0.53%	34,907 $542,000
Q1 2021 Apr 27, 2021	BUY	$14.49 - $20.72 $23,821 - $34,063	1,644 Added 4.97%	34,722 $563,000
Q4 2020 Jan 29, 2021	SELL	$14.61 - $22.14 $95,476 - $144,684	-6,535 Reduced 16.5%	33,078 $700,000
Q3 2020 Nov 10, 2020	SELL	$13.67 - $17.77 $244,009 - $317,194	-17,850 Reduced 31.06%	39,613 $587,000
Q2 2020 Aug 07, 2020	SELL	$10.89 - $21.47 $89,690 - $176,826	-8,236 Reduced 12.54%	57,463 $845,000
Q1 2020 Apr 28, 2020	SELL	$10.23 - $24.56 $98,586 - $236,684	-9,637 Reduced 12.79%	65,699 $771,000
Q4 2019 Feb 12, 2020	BUY	$17.42 - $26.61 $1,341 - $2,048	77 Added 0.1%	75,336 $1.77 Million
Q2 2019 Jul 30, 2019	BUY	$16.93 - $26.22 $135,710 - $210,179	8,016 Added 11.92%	75,259 $1.4 Million
Q3 2018 Oct 24, 2018	SELL	$30.0 - $40.85 $744,960 - $1.01 Million	-24,832 Reduced 26.97%	67,243 $2.13 Million
Q2 2018 Jul 09, 2018	SELL	$26.4 - $42.0 $512,846 - $815,892	-19,426 Reduced 17.42%	92,075 $3.58 Million
Q1 2018 May 11, 2018	SELL	$18.43 - $28.8 $951,024 - $1.49 Million	-51,602 Reduced 31.64%	111,501 $3.08 Million
Q1 2018 Apr 19, 2018	BUY	$18.43 - $28.8 $774,686 - $1.21 Million	42,034 Added 34.72%	163,103 $4.5 Million
Q4 2017 Jan 24, 2018	BUY	$14.8 - $18.85 $306,434 - $390,289	20,705 Added 20.63%	121,069 $2.19 Million
Q3 2017 Oct 17, 2017	BUY	$14.65 - $16.85 $1.47 Million - $1.69 Million	100,364	100,364 $1.62 Million

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account